4/10/2013

A study in PLOS Medicine found the shingles vaccine is 48% effective in Medicare patients, leading to lower zoster rates. The vaccine also was 59% effective in reducing post-herpetic neuralgia, which occurs 90 days or more after zoster.

Related Summaries